US Stock MarketDetailed Quotes

AXSM Axsome Therapeutics

Watchlist
  • 90.730
  • +0.990+1.10%
Close Dec 20 16:00 ET
  • 91.000
  • +0.270+0.30%
Post 20:01 ET
4.40BMarket Cap-13.79P/E (TTM)

Axsome Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Axsome Therapeutics Q3 2024 Earnings Date

Currency：USDNov 12, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
98.07M
104.76M
+6.69M
Beat Est.
+69.69%
+81.27%
+6.82%
EPS
-1.41
-1.34
+0.07
Beat Est.
-6.86%
-1.52%
+5.00%
Analyst Rating
Strong Buy

Dec 21, 2024

Axsome Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 10 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 121.466M--
--2024/Q4-- / 117.711M--
Nov 12, 20242024/Q3104.762M / 98.072M--
Aug 5, 20242024/Q287.166M / 86.933M--
May 6, 20242024/Q174.999M / 72.852M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 121.466M--
--2024/Q4-- / 117.711M--
Nov 12, 20242024/Q3104.762M / 98.072M--
Aug 5, 20242024/Q287.166M / 86.933M--
May 6, 20242024/Q174.999M / 72.852M--

Unlock Free Earnings Estimates

Axsome Therapeutics Earnings Reports

  • Axsome Therapeutics | 8-K: Axsome Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update

    Nov 12 13:12 ET

  • Axsome Therapeutics | 10-Q: Q3 2024 Earnings Report

    Nov 12 09:49 ET

  • Axsome Therapeutics | 10-Q: Q2 2024 Earnings Report

    Aug 5 16:33 ET

  • Axsome Therapeutics | 8-K: Axsome Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update

    Aug 5 07:08 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Dec 21, 2024

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Price
    % Chg

    No Data